Macrotrabecular-Massive Subtype Is Associated with a High Risk of the Recurrence of Hepatocellular Carcinoma
Open Access
- 8 January 2026
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (2) , 502
Abstract
Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide, mainly due to its high recurrence rate after curative treatments. The macrotrabecular-massive (MTM) subtype has recently been recognized as an aggressive histologic variant associated with vascular invasion and poor differentiation. This study aimed to investigate the prognostic impact of the MTM subtype on recurrence after surgical resection of HCC. Methods: We retrospectively reviewed 171 patients who underwent curative hepatic resection for HCC between January 2007 and December 2017 at Gangnam Severance Hospital, Seoul, Korea. Clinicopathologic parameters, including immune-related features such as lymphoid infiltration and tertiary lymphoid structures (TLSs), were evaluated. Recurrence-free survival (RFS) and overall survival (OS) were analyzed using Kaplan–Meier and Cox regression analyses. Results: During a median follow-up of 4.4 ± 3.4 years, 74 patients (43.3%) experienced recurrence. The MTM subtype was significantly more frequent in the recurrence group than in the non-recurrence group (47.3% vs. 21.6%, p < 0.001). Multivariate analysis identified MTM subtype as an independent predictor of recurrence (hazard ratio, 1.88; 95% CI, 1.14–3.10; p = 0.013). Lymphoid infiltration and TLSs were not associated with prognosis. Kaplan–Meier analysis showed higher recurrence in MTM-positive cases (p = 0.001), whereas OS did not differ significantly (p = 0.094). Conclusions: The macrotrabecular-massive subtype is an independent histopathologic predictor of recurrence after curative resection in HCC. Incorporating MTM subtype recognition into postoperative risk assessment may enhance patient stratification and inform future adjuvant therapy strategies.Keywords
Funding Information
- Yonsei University College of Medicine (6-2020-0099)
This publication has 33 references indexed in Scilit:
- Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancerImmunity, 2022
- Comparative Characterization of Lymphoid Infiltration in Different Molecular-Biological Subtypes of Invasive Breast CancerBulletin of Experimental Biology and Medicine, 2021
- Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysisJournal of Hepatology, 2019
- Macrotrabecular‐massive hepatocellular carcinomaHepatology, 2018
- Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classificationHepatology, 2018
- Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classificationJournal of Hepatology, 2017
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosisHepatology, 2014
- Human hepatocellular carcinomas with “Stemness”-related marker expression: keratin 19 expression and a poor prognosisHepatology, 2011
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targetsHepatology, 2006